Expert Opin Biol Ther
-
Publication Venue For
- Promising vaccines for treating glioblastoma.. 18:1159-1170. 2018
- Prospect of rindopepimut in the treatment of glioblastoma.. 17:507-513. 2017
- Technosphere insulin: inhaled prandial insulin.. 16:111-117. 2016
- Strategies to circumvent humoral immunity to adeno-associated viral vectors.. 15:845-855. 2015
- Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.. 15:79-94. 2015
- Bevacizumab for the treatment of high-grade glioma: an update after phase III trials.. 14:729-740. 2014
- Targeted inhibition of VEGF receptor 2: an update on ramucirumab.. 13:1187-1196. 2013
- Bevacizumab for the treatment of high-grade glioma.. 12:1101-1111. 2012
- Lipids and diabetic retinopathy.. 12:93-105. 2012
- Bispecific antibodies engage T cells for antitumor immunotherapy.. 11:843-853. 2011
- Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity.. 11:739-750. 2011
- Pharmacology and clinical applications of human recombinant antithrombin.. 10:1155-1168. 2010
- Adenovirus vaccine immunotherapy targeting WT1-expressing tumors.. 10:875-883. 2010
- RNA as performance-enhancers for dendritic cells.. 10:563-574. 2010
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.. 9:1087-1098. 2009
- Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer.. 9:331-339. 2009
- Meningococcal tetravalent conjugate vaccine.. 8:1941-1946. 2008
- Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.. 8:541-553. 2008
- CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.. 7:1257-1266. 2007
- Update on anti-CTLA-4 antibodies in clinical trials.. 7:1245-1256. 2007
- Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy.. 7:449-460. 2007
- Recent clinical progress in virus-based therapies for cancer.. 6:1123-1134. 2006
- Stem cells for the ischaemic heart.. 6:427-442. 2006
- Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action.. 5:1635-1646. 2005
- Virus-based therapies for colon cancer.. 5:1627-1633. 2005
- Infliximab for the treatment of early rheumatoid arthritis.. 5:405-417. 2005
- The colony-stimulating factors: use to prevent and treat neutropenia and its complications.. 4:1897-1910. 2004
- Regulatable aptamers in medicine: focus on antithrombotic strategies.. 4:1641-1647. 2004
- Gene delivery approaches to heart failure treatment.. 4:1413-1422. 2004
- Monoclonal antibodies for brain tumour treatment.. 4:1453-1471. 2004